CU Healthcare Innovation Fund

ClinOne, Inc. is a clinical trial management solution that develops a mobile application designed to enhance communication and streamline workflow among researchers, investigators, and research staff. Founded in 2013 and based in Greenwood Village, Colorado, ClinOne’s platform provides web and mobile access to essential clinical trial information, facilitating better interaction and engagement between researchers and patients. The application aims to improve clinical trial enrollment, retention, compliance at research sites, and overall patient experience. ClinOne offers a comprehensive suite of mobile technologies that centralize research efforts and deliver pertinent trial content to participants. Its clientele includes notable organizations such as Array Biopharma, Genentech, Actelion, Takeda, and Boston Scientific.

Eon Health is a healthcare technology company based in Denver, Colorado, that specializes in software solutions designed to enhance complex patient management. Founded in 2015 as Matrix Analytics and rebranded in 2018, Eon Health focuses on improving the way healthcare data is gathered, curated, and shared among professionals. Its EonDirect software platform integrates with hospitals' existing electronic health record (EHR) and electronic medical record (EMR) systems, providing an online dashboard that aids healthcare providers in diagnosing and treating complex diseases. The company currently collaborates with 31 hospitals to manage over 12,000 patients, ensuring that critical data is accessible to the right professionals at the right time.

Cured, Inc. is a healthcare technology company that specializes in developing digital marketing tools and customer relationship management platforms for the healthcare sector. Founded in 2018 and headquartered in San Francisco, with additional offices in Chicago and Denver, Cured offers solutions that connect health systems and organizations to patients and their families. The company's cloud-based platform focuses on network management, patient marketing, and customer experience, providing design and product development services that address the unique challenges faced by healthcare and life sciences organizations. By leveraging modern business tools and integrating contact centers with electronic medical records, Cured enables clients to enhance brand awareness, improve patient satisfaction, and create engaging digital experiences that foster better healthcare behaviors and outcomes.

ClinOne, Inc. is a clinical trial management solution that develops a mobile application designed to enhance communication and streamline workflow among researchers, investigators, and research staff. Founded in 2013 and based in Greenwood Village, Colorado, ClinOne’s platform provides web and mobile access to essential clinical trial information, facilitating better interaction and engagement between researchers and patients. The application aims to improve clinical trial enrollment, retention, compliance at research sites, and overall patient experience. ClinOne offers a comprehensive suite of mobile technologies that centralize research efforts and deliver pertinent trial content to participants. Its clientele includes notable organizations such as Array Biopharma, Genentech, Actelion, Takeda, and Boston Scientific.

IMTherapeutics is a biotechnology company focused on creating personalized immunotherapeutic drugs for autoimmune diseases, utilizing genetic insights linked to human leukocyte antigen (HLA) genes. Founded in 2015 and based in Aurora, Colorado, the company’s lead candidate is an oral medication designed to inhibit the autoimmune process in type 1 diabetes (T1D) by targeting specific immune cells. This approach aims to preserve the function of pancreatic beta cells and support normal insulin production in patients at risk or in the early stages of T1D. Additionally, IMTherapeutics is leveraging its HLA platform to expand its drug pipeline to include treatments for Celiac disease and potentially other autoimmune disorders. The company employs advanced screening techniques and rational drug design to develop targeted therapeutic candidates, enhancing early detection and management of autoimmune conditions.